These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. HIF-prolyl hydroxylases and cardiovascular diseases. Sen Banerjee S; Thirunavukkarasu M; Tipu Rishi M; Sanchez JA; Maulik N; Maulik G Toxicol Mech Methods; 2012 Jun; 22(5):347-58. PubMed ID: 22424133 [TBL] [Abstract][Full Text] [Related]
5. Hypoxic preconditioning produces differential expression of hypoxia-inducible factor-1alpha (HIF-1alpha) and its regulatory enzyme HIF prolyl hydroxylase 2 in neonatal rat brain. Jones NM; Lee EM; Brown TG; Jarrott B; Beart PM Neurosci Lett; 2006 Aug; 404(1-2):72-7. PubMed ID: 16828226 [TBL] [Abstract][Full Text] [Related]
6. Pre- and post-conditional inhibition of prolyl-4-hydroxylase domain enzymes protects the heart from an ischemic insult. Vogler M; Zieseniss A; Hesse AR; Levent E; Tiburcy M; Heinze E; Burzlaff N; Schley G; Eckardt KU; Willam C; Katschinski DM Pflugers Arch; 2015 Oct; 467(10):2141-9. PubMed ID: 25578858 [TBL] [Abstract][Full Text] [Related]
7. Prolyl Hydroxylase Inhibitors: a New Opportunity in Renal and Myocardial Protection. Requena-Ibáñez JA; Santos-Gallego CG; Rodriguez-Cordero A; Zafar MU; Badimon JJ Cardiovasc Drugs Ther; 2022 Dec; 36(6):1187-1196. PubMed ID: 34533692 [TBL] [Abstract][Full Text] [Related]
8. Things get broken: the hypoxia-inducible factor prolyl hydroxylases in ischemic heart disease. Schreiber T; Salhöfer L; Quinting T; Fandrey J Basic Res Cardiol; 2019 Mar; 114(3):16. PubMed ID: 30859331 [TBL] [Abstract][Full Text] [Related]
9. The prolyl 4-hydroxylase inhibitor GSK360A decreases post-stroke brain injury and sensory, motor, and cognitive behavioral deficits. Zhou J; Li J; Rosenbaum DM; Zhuang J; Poon C; Qin P; Rivera K; Lepore J; Willette RN; Hu E; Barone FC PLoS One; 2017; 12(9):e0184049. PubMed ID: 28880966 [TBL] [Abstract][Full Text] [Related]
10. Novel perspectives on the PHD-HIF oxygen sensing pathway in cardioprotection mediated by IPC and RIPC. Martin-Puig S; Tello D; Aragonés J Front Physiol; 2015; 6():137. PubMed ID: 26042040 [TBL] [Abstract][Full Text] [Related]
12. Neuroprotection by hypoxic preconditioning involves upregulation of hypoxia-inducible factor-1 in a prenatal model of acute hypoxia. Giusti S; Fiszer de Plazas S J Neurosci Res; 2012 Feb; 90(2):468-78. PubMed ID: 21953610 [TBL] [Abstract][Full Text] [Related]
13. The protective effect of prolyl-hydroxylase inhibition against renal ischaemia requires application prior to ischaemia but is superior to EPO treatment. Wang Z; Schley G; Türkoglu G; Burzlaff N; Amann KU; Willam C; Eckardt KU; Bernhardt WM Nephrol Dial Transplant; 2012 Mar; 27(3):929-36. PubMed ID: 21742784 [TBL] [Abstract][Full Text] [Related]
14. Organ protection by hypoxia and hypoxia-inducible factors. Bernhardt WM; Warnecke C; Willam C; Tanaka T; Wiesener MS; Eckardt KU Methods Enzymol; 2007; 435():221-45. PubMed ID: 17998057 [TBL] [Abstract][Full Text] [Related]